EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease

Thomas Guieysse, Roxane Lamothe, Marion Houot, Solofo Razafimahatratra, Takfarinas Medani, François-Xavier Lejeune, Gérard Dreyfus, André Klarsfeld, Dimitrios Pantazis, Etienne Koechlin, Katia Andrade

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-230552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Thomas Guieysse und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), AP-HP, Pitié-Salpêtrière Hospital, Paris, France. Hauptthemen laut MEDLINE: Alzheimer Disease, Agnosia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Though not originally developed for this purpose, the Healthy Aging Brain Care Monitor (HABC-M) seems a valuable instrument for assessing anosognosia in Alzheimer’s disease (AD).

Objectives

Our study aimed at 1) investigating the validity of the HABC-M (31 items), and its cognitive, psychological, and functional subscales, in discriminating AD patients from controls; 2) exploring whether the HABC-M discrepancy scores between the self-reports of patients/controls in these different domains and the respective ratings provided by their caregivers/informants correlate with an online measure of self-awareness; 3) determining whether the caregiver burden level, also derived from the HABC-M, could add additional support for detecting anosognosia.

Methods

The HABC-M was administered to 30 AD patients and 30 healthy controls, and to their caregivers/informants. A measure of online awareness was established from subjects’ estimation of their performances in a computerized experiment.

Results

The HABC-M discrepancy scores distinguished AD patients from controls. The cognitive subscale discriminated the two groups from the prodromal AD stage, with an AUC of 0.88 [95% CI: 0.78;0.97]. Adding the caregiver burden level raised it to 0.94 [0.86;0.99]. Significant correlations between the HABC-M and online discrepancy scores were observed in the patients group, providing convergent validity of these methods.

Conclusions

The cognitive HABC-M (six items) can detect anosognosia across the AD spectrum. The caregiver burden (four items) may corroborate the suspicion of anosognosia. The short-hybrid scale, built from these 10 items instead of the usual 31, showed the highest sensitivity for detecting anosognosia from the prodromal AD stage, which may further help with timely diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAgnosiaHumansProdromal SymptomsCaregiversBrainNeuropsychological Tests

Stichwörter der Autor:innen

Alzheimer’s diseaseHABC-Manosognosia assessmentcaregiver burdenerror-monitoringtimely diagnosis

Autor:innen und Institutionen

  • Department of Neurology, Institute of Memory and Alzheimer's Disease (IM2A), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Centre of Excellence of Neurodegenerative Disease (CoEN), AP-HP, Pitié-Salpêtrière Hospital, Paris, France.
  • Signal & Image Processing Institute, University of Southern California, Los Angeles, CA, USA.
  • Paris Brain Institute (Institut du Cerveau, ICM), Data Analysis Core, INSERM, CNRS, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne Université, Pitié-Salpêtrière University Hospital, Paris, France.
  • ESPCI Paris - PSL, Paris, France.
  • Laboratory of Brain Plasticity, CNRS UMR 8249, ESPCI Paris - PSL, Paris, France.

Förderung

  • NIA NIH HHS

Zitieren

APA

Guieysse, T., Lamothe, R., Houot, M., Razafimahatratra, S., Medani, T., Lejeune, F. X., Dreyfus, G., Klarsfeld, A., Pantazis, D., Koechlin, E., & Andrade, K. (2023). Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230552

Vancouver

Guieysse T, Lamothe R, Houot M, Razafimahatratra S, Medani T, Lejeune FX, et al. Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-230552

BibTeX
@article{Guieysse2023,
  author = {Guieysse, Thomas and Lamothe, Roxane and Houot, Marion and Razafimahatratra, Solofo and Medani, Takfarinas and Lejeune, François-Xavier and Dreyfus, Gérard and Klarsfeld, André and Pantazis, Dimitrios and Koechlin, Etienne and Andrade, Katia},
  title = {Detecting Anosognosia from the Prodromal Stage of Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-230552}
}
Kostenlos starten →